RedHill Biopharma Ltd. (RDHL)

2.17

-0.24 (-9.96%)

At close: Apr 28, 2025, 3:59 PM

2.19

0.69%

After-hours: Apr 28, 2025, 07:42 PM EDT

RedHill Biopharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	4.62M	5.57M	19.97M	29.47M	29.3M	29.02M	29M	16.45M	53.79M
Short-Term Investments	n/a	790.04K	15K	8.53M	498K	18.85M	24.18M	29.75M	12.37M
Long-Term Investments	n/a	147K	150K	16.17M	16.16M	152K	140K	152K	137K
Other Long-Term Assets	148K	34.00	150K	16.17M	16.16M	-20.73M	-5.62M	152K	137K
Receivables	3.57M	3.29M	37.88M	32.52M	29.29M	1.64M	1.4M	2.26M	492K
Inventory	3.65M	4.39M	11.01M	14.81M	6.53M	1.88M	769K	653K	1.11M
Other Current Assets	n/a	790K	16M	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Assets	11.91M	16.14M	85.9M	89.15M	70.5M	53.21M	56.79M	51.68M	67.81M
Property-Plant & Equipment	437K	1.18M	7.19M	4.22M	5.7M	3.81M	163K	230K	165K
Goodwill & Intangibles	5.55M	5.58M	65.63M	71.64M	87.88M	16.93M	5.32M	5.29M	6.09M
Total Long-Term Assets	6.13M	6.91M	72.97M	92.04M	109.75M	20.89M	5.62M	5.67M	6.4M
Total Assets	18.04M	23.05M	158.87M	181.19M	180.24M	74.1M	62.41M	57.34M	74.21M
Account Payables	7.86M	3.28M	4.23M	11.66M	11.55M	4.18M	3.32M	4.8M	60K
Deferred Revenue	n/a	n/a	n/a	37.31M	41.63M	5.49M	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	115.22M	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	11.31M	12.22M	49.65M	34.37M	23.45M	2.6M	1.46M	1.06M	393K
Total Current Liabilities	22.22M	19.98M	197.45M	81.47M	73.23M	10.62M	10.38M	11.83M	5.36M
Long-Term Debt	n/a	n/a	n/a	83.62M	81.39M	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	500K	1.28M	3.37M	4.65M	7.95M	500K	844K	448K	6.16M
Total Long-Term Liabilities	503K	1.74M	9.82M	90.84M	93.14M	3.48M	844K	448K	6.16M
Total Liabilities	22.73M	20.98M	207.27M	172.31M	166.38M	14.1M	11.22M	12.28M	11.51M
Total Debt	356K	1.17M	122.69M	87.81M	86.9M	3.81M	n/a	n/a	n/a
Common Stock	35.04M	21.44M	2.83M	1.5M	1.05M	962K	767K	575K	441K
Retained Earnings	-414.8M	-407.74M	-433.86M	-367.87M	-280.33M	-208.36M	-169.09M	-132.94M	-89.64M
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	n/a	-341K	-251K	-170K
Shareholders Equity	-4.68M	2.07M	-48.4M	8.88M	13.86M	60M	51.19M	45.06M	62.7M
Total Investments	n/a	147K	15K	8.53M	498K	19M	45.59M	38.05M	12.52M